vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Urban Edge Properties (UE). Click either name above to swap in a different company.

Urban Edge Properties is the larger business by last-quarter revenue ($132.6M vs $83.1M, roughly 1.6× PROCEPT BioRobotics Corp). Urban Edge Properties runs the higher net margin — 17.1% vs -38.1%, a 55.1% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 12.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 11.6%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Urban Edge Properties is a publicly traded real estate investment trust (REIT) that owns, operates, and develops high-quality retail and mixed-use properties, primarily located in densely populated urban and suburban markets across the United States. Its portfolio covers grocery-anchored shopping centers, lifestyle outlets, and community-focused commercial assets.

PRCT vs UE — Head-to-Head

Bigger by revenue
UE
UE
1.6× larger
UE
$132.6M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+8.0% gap
PRCT
20.2%
12.2%
UE
Higher net margin
UE
UE
55.1% more per $
UE
17.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
11.6%
UE

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
PRCT
PRCT
UE
UE
Revenue
$83.1M
$132.6M
Net Profit
$-31.6M
$22.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
-38.1%
17.1%
Revenue YoY
20.2%
12.2%
Net Profit YoY
-27.9%
-6.7%
EPS (diluted)
$-0.56
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
UE
UE
Q1 26
$83.1M
$132.6M
Q4 25
$76.4M
$119.6M
Q3 25
$83.3M
$120.1M
Q2 25
$79.2M
$114.1M
Q1 25
$69.2M
$118.2M
Q4 24
$68.2M
$116.4M
Q3 24
$58.4M
$112.4M
Q2 24
$53.4M
$106.5M
Net Profit
PRCT
PRCT
UE
UE
Q1 26
$-31.6M
$22.6M
Q4 25
$-29.8M
$12.4M
Q3 25
$-21.4M
$14.9M
Q2 25
$-19.6M
$58.0M
Q1 25
$-24.7M
$8.2M
Q4 24
$-18.9M
$30.1M
Q3 24
$-21.0M
$9.1M
Q2 24
$-25.6M
$30.8M
Gross Margin
PRCT
PRCT
UE
UE
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
UE
UE
Q1 26
-4.1%
Q4 25
-40.6%
11.3%
Q3 25
-27.8%
13.4%
Q2 25
-28.0%
53.9%
Q1 25
-39.7%
7.6%
Q4 24
-28.9%
27.6%
Q3 24
-38.4%
8.9%
Q2 24
-50.3%
30.6%
Net Margin
PRCT
PRCT
UE
UE
Q1 26
-38.1%
17.1%
Q4 25
-39.1%
10.4%
Q3 25
-25.7%
12.4%
Q2 25
-24.7%
50.8%
Q1 25
-35.8%
6.9%
Q4 24
-27.6%
25.9%
Q3 24
-35.9%
8.1%
Q2 24
-48.0%
28.9%
EPS (diluted)
PRCT
PRCT
UE
UE
Q1 26
$-0.56
$0.18
Q4 25
$-0.54
$0.09
Q3 25
$-0.38
$0.12
Q2 25
$-0.35
$0.46
Q1 25
$-0.45
$0.07
Q4 24
$-0.34
$0.25
Q3 24
$-0.40
$0.07
Q2 24
$-0.50
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
UE
UE
Cash + ST InvestmentsLiquidity on hand
$245.6M
$50.0M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$1.4B
Total Assets
$487.1M
$3.4B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
UE
UE
Q1 26
$245.6M
$50.0M
Q4 25
$286.5M
$48.9M
Q3 25
$294.3M
$77.8M
Q2 25
$302.7M
$53.0M
Q1 25
$316.2M
$48.0M
Q4 24
$333.7M
$41.4M
Q3 24
$196.8M
$67.9M
Q2 24
$214.1M
$78.6M
Total Debt
PRCT
PRCT
UE
UE
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
UE
UE
Q1 26
$347.7M
$1.4B
Q4 25
$365.9M
$1.4B
Q3 25
$380.3M
$1.4B
Q2 25
$385.8M
$1.4B
Q1 25
$389.2M
$1.4B
Q4 24
$402.2M
$1.4B
Q3 24
$241.2M
$1.3B
Q2 24
$251.8M
$1.3B
Total Assets
PRCT
PRCT
UE
UE
Q1 26
$487.1M
$3.4B
Q4 25
$508.1M
$3.3B
Q3 25
$511.5M
$3.3B
Q2 25
$513.1M
$3.3B
Q1 25
$519.4M
$3.3B
Q4 24
$534.0M
$3.3B
Q3 24
$374.1M
$3.2B
Q2 24
$374.4M
$3.2B
Debt / Equity
PRCT
PRCT
UE
UE
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
UE
UE
Operating Cash FlowLast quarter
$39.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
UE
UE
Q1 26
$39.1M
Q4 25
$-10.3M
$182.7M
Q3 25
$-6.6M
$55.7M
Q2 25
$-15.0M
$43.5M
Q1 25
$-17.0M
$32.6M
Q4 24
$-32.4M
$153.2M
Q3 24
$-18.8M
$36.6M
Q2 24
$-15.7M
$41.2M
Free Cash Flow
PRCT
PRCT
UE
UE
Q1 26
Q4 25
$-12.2M
$81.8M
Q3 25
$-9.5M
$26.1M
Q2 25
$-17.8M
$19.6M
Q1 25
$-18.8M
$11.9M
Q4 24
$-33.6M
$42.5M
Q3 24
$-19.0M
$12.2M
Q2 24
$-16.8M
$19.9M
FCF Margin
PRCT
PRCT
UE
UE
Q1 26
Q4 25
-15.9%
68.4%
Q3 25
-11.4%
21.7%
Q2 25
-22.5%
17.2%
Q1 25
-27.2%
10.0%
Q4 24
-49.2%
36.6%
Q3 24
-32.6%
10.8%
Q2 24
-31.4%
18.6%
Capex Intensity
PRCT
PRCT
UE
UE
Q1 26
1.5%
Q4 25
2.4%
84.4%
Q3 25
3.4%
24.6%
Q2 25
3.5%
20.9%
Q1 25
2.7%
17.5%
Q4 24
1.7%
95.1%
Q3 24
0.4%
21.7%
Q2 24
2.0%
20.1%
Cash Conversion
PRCT
PRCT
UE
UE
Q1 26
1.73×
Q4 25
14.71×
Q3 25
3.73×
Q2 25
0.75×
Q1 25
3.97×
Q4 24
5.09×
Q3 24
4.03×
Q2 24
1.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

UE
UE

Rental revenue$124.2M94%
Other$8.4M6%

Related Comparisons